# US 2010/0137606 A1 · Novel compound having beta-secretase inhibitory activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0137606 A1
- Document ID: US20100137606A1
- Status: Published application
- Kind: A1
- Application number: 12/452,234
- Filed: 2008-06-21
- Published: 2010-06-03
- Earliest claimed: 2007-06-22
- Inventors: Yoshiaki Kiso
- Web page: https://patentgrep.com/patent/US20100137606A1

## CPC

- C07D 213/81: Amides; Imides
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 405/14: containing three or more hetero rings
- C07D 413/14: containing three or more hetero rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A novel compound represented by the formula (1) below which has β-secretase inhibitory activity, its pharmaceutically acceptable salt or a prodrug thereof. wherein Ar is a substituted or unsubstituted 5 to 6 membered mono cyclic aromatic group; R1, R2 and R3 are hydrogen atom, substituted or unsubstituted alkyl group or the like, or R2 and R3 may be taken together with the adjacent nitrogen atom and carbon atom respectively to form a 3 to 6 membered ring; R4 is C1-6 alkyl group, C1-6 alkyl group substituted by phenyl, phenylthio, or a hetero ring, or the like; A is represented by the formula below: wherein X and Y are oxygen atom, NH or sulfur atom, Z is hydrogen atom, hydroxy group which may be substituted, amino group, thiol group, or the like; and B is hydroxy group, substituted or unsubstituted amino group, substituted or unsubstituted aliphatic or aromatic amino group, or the like.

## Claims

### Claim 1

A compound represented by the following formula (I):
wherein Ar is a substituted or unsubstituted 5 to 6 membered mono cyclic aromatic group, and said aromatic group may have a hetero atom selected from nitrogen atom, oxygen atom and sulfur atom; R1, R2 and R3 are hydrogen atom, substituted or unsubstituted alkyl group, substituted or unsubstituted allyl group, or substituted or unsubstituted aryl group, nitro group, halogen atom, cyano group, hydroxy group or its derivative, or carboxy group or its derivative, and R2 and R3 may be taken together with the adjacent nitrogen atom and carbon atom respectively to form a 3 to 6 membered ring which may be interrupted by oxygen atom, sulfur atom or substituted or unsubstituted amino group; R4 is C1-6 alkyl group, C2-6 alkenyl group, C2-6 alkinyl group, C3-7 cycloalkyl group, phenyl group, C1-6 alkyl group substituted by phenyl, phenylthio or a hetero ring provided that said phenyl, said phenylthio and said hetero ring may be substituted by C1-6 alkyl, hydroxy, nitro, halogen, —SO3H or —PO4H;
A is represented by the formula:
wherein X and Y are oxygen atom, NH or sulfur atom, Z is hydrogen atom, hydroxy group, amino group, or thiol group, and when Z is hydroxy group, amino group or thiol group, said group may be substituted by substituted or unsubstituted alkyl group, substituted or unsubstituted allyl group, or substituted or unsubstituted aryl group, substituted or unsubstituted acyl group, substituted or unsubstituted alkylsulfonyl group, substituted or unsubstituted arylsulfonyl group, or substituted or unsubstituted allylsulfonyl group; and B is hydroxy group, substituted or unsubstituted amino group, substituted or unsubstituted hydrazino group, substituted or unsubstituted hydroxyamino group, or substituted or unsubstituted aliphatic or aromatic amino group,
or its pharmaceutically acceptable salt or a prodrug thereof.

### Claim 2 (depends on 1)

The compound according to claim 1 wherein in the generic formula (1) Ar is a substituted or unsubstituted phenyl group, R1, R2 and R3 are hydrogen atom, substituted or unsubstituted alkyl group, and R2 and R3 may be taken together with the adjacent nitrogen atom and carbon atom respectively to form a 3 to 6 membered ring which may be interrupted by oxygen atom, sulfur atom or substituted or unsubstituted amino group; and B is hydroxy group, substituted or unsubstituted amino group, or the following formula:
wherein L1 and L2 are hydrogen atom, substituted or unsubstituted alkyl group, substituted or unsubstituted allyl, substituted or unsubstituted aryl, nitro group, halogen atom, cyano group, hydroxy group or its derivative, carboxy group or its derivative, or a group biologically equivalent to a carboxyl group,
or its pharmaceutically acceptable salt or a prodrug thereof.

### Claim 3 (depends on 2)

The compound according to claim 2 wherein in B1 of B of the generic formula (1), either L1 or L2 is a group biologically equivalent to a carboxyl group which is selected from the following groups:
or its pharmaceutically acceptable salt or a prodrug thereof.

### Claim 4 (depends on 1)

The compound according to claim 1 wherein R4 of the generic formula (1) is a group selected from following groups:
wherein Q is hydrogen atom, C1-6 alkyl group, hydroxy group, nitro group, halogen atom, —SO3H or —PO4H,
or its pharmaceutically acceptable salt or a prodrug thereof.

### Claim 5 (depends on 1)

A medicament containing a compound claimed in claim 1, its pharmaceutically acceptable salt or a prodrug thereof as an active ingredient.

### Claim 6 (depends on 1)

A β-secretase inhibitor containing a compound claimed in claim 1, its pharmaceutically acceptable salt or a prodrug thereof as an active ingredient.

### Claim 7 (depends on 2)

A medicament containing a compound claimed in claim 2, its pharmaceutically acceptable salt or a prodrug thereof as an active ingredient.

### Claim 8 (depends on 3)

A medicament containing a compound claimed in claim 3, its pharmaceutically acceptable salt or a prodrug thereof as an active ingredient.

### Claim 9 (depends on 4)

A medicament containing a compound claimed in claim 4, its pharmaceutically acceptable salt or a prodrug thereof as an active ingredient.

### Claim 10 (depends on 2)

A β-secretase inhibitor containing a compound claimed in claim 2, its pharmaceutically acceptable salt or a prodrug thereof as an active ingredient.

### Claim 11 (depends on 3)

A β-secretase inhibitor containing a compound claimed in claim 3, its pharmaceutically acceptable salt or a prodrug thereof as an active ingredient.

### Claim 12 (depends on 4)

A β-secretase inhibitor containing a compound claimed in claim 4, its pharmaceutically acceptable salt or a prodrug thereof as an active ingredient.
